These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15824177)

  • 21. Associations between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 genotypes and haplotypes in the vitamin D receptor gene, ultraviolet radiation and susceptibility to prostate cancer.
    Moon S; Holley S; Bodiwala D; Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
    Ann Hum Genet; 2006 Mar; 70(Pt 2):226-36. PubMed ID: 16626332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
    Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
    Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer].
    Liu JH; Li HW; Tong M; Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):364-8. PubMed ID: 15061984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese.
    Watanabe M; Fukutome K; Murata M; Uemura H; Kubota Y; Kawamura J; Yatani R
    Anticancer Res; 1999; 19(5C):4511-4. PubMed ID: 10650802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.
    Szendroi A; Speer G; Tabak A; Kosa JP; Nyirady P; Majoros A; Romics I; Lakatos P
    Can J Urol; 2011 Jun; 18(3):5710-6. PubMed ID: 21703046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes.
    Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
    Br J Cancer; 2001 Nov; 85(10):1504-9. PubMed ID: 11720436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
    McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
    Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population.
    Lemos MC; Fagulha A; Coutinho E; Gomes L; Bastos M; Barros L; Carrilho F; Geraldes E; Regateiro FJ; Carvalheiro M
    Hum Immunol; 2008 Feb; 69(2):134-8. PubMed ID: 18361940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between polymorphisms in the vitamin D receptor and breast cancer risk.
    Chen WY; Bertone-Johnson ER; Hunter DJ; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2335-9. PubMed ID: 16214913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
    Mittal RD; Manchanda PK; Bhat S; Bid HK
    BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
    Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
    Hayes VM; Severi G; Eggleton SA; Padilla EJ; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):993-6. PubMed ID: 15824176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No association between common chemokine and chemokine receptor gene variants and prostate cancer risk.
    Petersen DC; Severi G; Hoang HN; Padilla EJ; Southey MC; English DR; Hopper JL; Giles GG; Hayes VM
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3615-7. PubMed ID: 19064579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
    Fukatsu T; Hirokawa Y; Araki T; Hioki T; Murata T; Suzuki H; Ichikawa T; Tsukino H; Qiu D; Katoh T; Sugimura Y; Yatani R; Shiraishi T; Watanabe M
    Anticancer Res; 2004; 24(4):2431-7. PubMed ID: 15330195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer.
    Yaylim-Eraltan I; Arzu Ergen H; Arikan S; Okay E; Oztürk O; Bayrak S; Isbir T
    Cell Biochem Funct; 2007; 25(6):731-7. PubMed ID: 17243190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.